Electro Cancer Therapy (ECT) is the treatment of accessible, solid tumours with weak direct current that brings about the necrosis (death) of tumour cells and thus leads to the dissolution of tumours. It is a very effective cancer treatment that does not need any scalpels, radiation or chemicals. Other names for ECT include galvanotherapy, percutaneous electrochemical tumour therapy or tumour galvanolysis.
The active principle of ECT therapy focuses specifically on the metabolism of cancer cells / tumour cells while protecting healthy tissue. This is gentle on the patient but fatal for the tumour. In the majority of cases, ECT treatment is only slightly painful, if indeed there is any pain at all, and has few negative side effects. A positive side effect of ECT is that it stimulates the immune system. ECT should not be confused with hyperthermia, irreversible electroporation (IRE) or other forms of electrotherapy.
Through the pioneering work of Dr. Rudolf Pekar from Bad Ischl (Austria), who has been refining the technique of galvanotherapy and publishing his findings since the early 1970s, as well as through Swedish, Austrian and US researchers, we are now able to perform tumour therapy with galvanic currents successfully. ECT is currently used, among others, in Germany, Austria, Switzerland, Denmark, Italy, Russia and China with great success. It should be emphasised that with ECT, the risk of metastasis is virtually non-existent because such metastases are preventatively counteracted. ECT is about complex electrical sequences in the metabolism of the organism or the cell, with a strong effect on the bioelectrical and biochemical processes in the tumour tissue.
Nothing is more powerful than an idea at the right time.
ECT is a real alternative to conventional cancer therapy
University Lecturer Dr. Ferdinand Ruzicka, head of the working group on electron microscopy of the Institute of Human Biology, Vienna, describes ECT as follows: "(ECT) ... is a biophysical method for ambulatory performance of therapy on all accessible tumours which is unproblematic, harmless and painless under local anaesthesia. It allows remarkable efficiency, is replicable, transparent and harmless, even in combination with conventional methods". Even the Medical Health Insurance Services (MDK) of Bavaria, which is purely oriented to conventional medicine, wrote in a report dated 01.06.1999 on ECT (galvanotherapy): "The theoretical concept is based on reproducible potential differences between damaged tissues and surrounding areas. The most recent research on ECT was presented at a congress in September 1993 in Stockholm. The most widely usage is found in China, where it has been used on more than 9,000 patients since 1987. To date, lung, liver, breast, skin, nose and throat tumours have been treated as well as melanomas and sarcomas amongst others. The response rates (complete and partial remission) are given as about 78% for short-term and a 5-year survival rates of 59% at 1,400 re-tested patients. The procedure is used either alone, in combination with radiotherapy, combined with drugs (chemotherapy as monotherapy or combination therapy, systemically or locally; hormones, interferon alpha) or with hyperthermia".
The Medical Health Insurance Services (MDK) of Bavaria makes the following key statement in its recommendation: "ECT is based on knowledge of electrophysiology and electrochemistry. The concept is rationally based and seems conclusive."
Up until now, the medical treatment of cancer was mainly focused on the surgical reduction or removal of the tumour, with subsequent chemotherapy and / or radiotherapy. The frequently occurring side effects of these forms of therapy are well-known: nausea, vomiting, weakness, significant weakening of the immune system and severe impact on quality of life. Electro Cancer Therapy (ECT) has been hitherto little noticed or ignored in the medical field, but new scientific approaches have led to new insights into energetic medicine. Clinical studies from Germany and abroad prove the effectiveness of ECT-tumour treatment with mostly positive results (see studies). This confirms the thesis of Dr. rer. nat. U. Warnke, University of Saarbrücken (Germany): "The paradigm shift is already taking place. The future of medicine is electric current ".
Conclusion : Electro Cancer Therapy (ECT) a method of tumour depolarisation (tumour destruction) based on biophysical principles.
Expertly applied ECT can only help, not harm
We assume at this point that the patient’s own body can selectively remove the necrotised tumour mass, and that there is no breach (e.g. when tumours are located at the outer border of an organ) or unwanted infiltration of tumour cells. If this is ensured by a solid diagnosis and a cautious dosage of the galvanic current by a specially trained and certified therapist, then the headline’s claim is true and ECT can only help, not harm. ECT only affects the metabolic system of the tumour cells and at the same time has a positive effect on the immunisation process. To do this, electrodes are applied to and around the area of the tumour via which a weak direct current is applied through the targeted area. The electrical resistance of tumour cells is significantly lower than that of healthy cells. The weak current can thus focus destructively on the tumour cells while not affecting healthy tissue due to its different structure. In this way, tumours are killed off progressively in a sterile manner (aseptic necrobiosis), often even in a single session of up to three hours‘ duration. Gradually, the tissue is rejected by the healthy body or metabolised by phagocytes of the immune system.
During treatment, an electric field is set up and charged particles (ions) are drawn to the opposite poles (electrolysis), Na+ and H+ ions for example to the cathode (negative pole) and Cl- ions to the anode (positive pole). Thus an alkaline region is formed around the cathode and an acidic environment around the anode. The pH values in both cases are far outside the physiological range and have a destructive effect on tumour tissue. The membrane potential of individual tumour cells changes with changes in the electrolytic environment in and around each cell. The increased flow of ions leads to perforation of the membrane, and disruption of metabolic functions and intracellular structures. The cell is attacked by immune cells, because they are no longer electrically repelled. At the same time tumour antigens are released and increasingly recognized by attracted immune cells. A new metastasis formation is effectively counteracted, partly also because a potential difference was applied even as the electrodes were being positioned and so any detached tumour cells are held in the electric field and consequently killed.
Dr. Rudolf Pekar refined ECT therapy from historical galvanotherapy. Electric current is used in many areas of medicine. The tissue-destructive properties of current have been known since the 18th century. Italian researcher Luigi Galvani discovered these properties by experiments. Later, in the 19th century, the Parisian dermatologist F.J. Darier reported curing malignant melanoma by percutaneous (introduced through the skin) needle electrodes and direct current. The Austrian physician Dr. Rudolf Pekar carried out pioneering work based on this. Since the early 1970s, he refined the technique of galvanotherapy. Dr. Rudolf Pekar published his findings in a scientific magazine. In America and Sweden too, tumour therapy using direct current based on his new research results was used and developed further. The form of tumour therapy with galvanic currents researched by Dr. Rudolf Pekar is successfully practised by doctors and naturopaths (medical practitioners) today. It should be noted that only therapists with the device type ECT G8 are certified to fully administer this therapy. The device types BET 7 and ECT Plus are approved only for flat electrodes and therefore of limited use. Some medical practitioners use these devices illegally for the needle electrode technique.